Human fetal pituitary expresses functional growth hormone-releasing peptide receptors

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 1, 1998, Pages 174-178

  Shimon, Ilan ^a   Yan, Xinmin ^a   Melmed, Shlomo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE RELEASING FACTOR; PROLACTIN;

ARTICLE; CORTICOTROPIN RELEASE; DOSE RESPONSE; FETUS; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; HYPOPHYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENOCORTICOTROPIC HORMONE; ADULT; CELLS, CULTURED; FEMALE; FETUS; GESTATIONAL AGE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KINETICS; OLIGOPEPTIDES; PITUITARY GLAND; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROLACTIN; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; RNA, MESSENGER; SOMATOSTATIN; TRANSCRIPTION, GENETIC;

EID: 0031792737     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.1.174     Document Type: Article

References (35)

1. Barinaga M, Yamanoto G, Rivier G, Vale W, Evans R, Rosenfeld MG. 1983 Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature. 306:84-86.
2. Lamberts SWJ. 1988 The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the teratment of human pituitary tumors. Endocr Rev. 9:417-436.
3. Yamashita S, Melmed S. 1987 Insulin-like growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells. J Clin Invest. 79:449-452.
4. Bowers CY, Momany FA, Chang D, Hong A, Chang K. 1980 Structure-activity relationships of a synthetic pentapeptide that specifically releases GH in vitro. Endocrinology. 106:663-667.
5. Momany FA, Bowers CY, Reynolds GA, Newlander K. 1984 Conformational energy studies and in vitro activity data on active GH-releasing peptides. Endocrinology. 114:1531-1536.
6. Bowers CY, Momany FA, Reynolds GA, Hong A. 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 114:1337-1545.
7. Bowers CY, Sartor AO, Reynolds GA, Hong A. 1491 On the actions of the growth hormone-releasing hexapeptide, GHRP-6. Endocrinology. 128:2027-2035.
8. Codd EE, Shu AYL, Walker RF. 1989 Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology. 28:1139-1144.
9. Howard AD, Feighner SD, Cully DF, et al. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:974-977.
10. Smith RG, Cheng K, Schoen WR, et al. 1993 A nonpeptidyl growth hormone secretagogue. Science. 260:1640-1643.
11. Patchett AA, Nargund RP, Tata JR, et al. 1995 Design and biological activities of 1.-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci USA. 92:7001-7005.
12. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO. 1990 Growth hormone(GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 70:975-982.
13. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF. 1995 Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab. 80:942-947.
14. Korbonits M, Grossman AB. 1995 Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release. Trends Endocrinol Metab. 6:43-49.
15. 2-induced growth hormone release from rat primary pituitary cells. Endocrinology. 129:3337-3342.
16. Hartman ML, Farello G, Pezzoli SS, Thorner MO. 1992 Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men. J Clin Endocrinol Metab. 74:1378-1384.
17. Bowers CY, Alster DK, Frentz JM. 1992 The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short-statured children after oral administration. J Clin Endocrinol Metab. 74:242-298.
18. Pihoker C, Middleton R, Reynolds GA, Bowers CY, Badger TM. 1995 Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature. J Clin Endocrinol Metab. 80:2987-2992.
19. McDowell RS, Elias KA, Stanley MS, et al. 1995 Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation. Proc Natl Acad Sci USA. 92:11165-11169.
20. Elias KA, Ingle GS, Burnier JP, et al. 1995 In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology. 136:5694-5699.
21. Soliman EB, Hashizume T, Kanematsu S. 1994 Effect of growth hormone (GH)-releasing pepticle (GHRP) on the release of GH from cultured anterior pituitary cells in cattle. Endocr J. 41:585-591.
22. Wu D, Chen C, Katoh K, Clarke IJ. 1994 The effect of GH-releasing-peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist. J Endocrinol. 140:R9-R13.
23. Shimon I, Taylor JE, Dong JZ, et al. 1997 Somatostatin receptor subtype specificity in human fetal pituitary cultures: differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone and prolactin regulation. J Clin Invest. 99:789-798.
24. Cohen CB, Jonsen AR. 1993 National Advisory Panel on ethics in reproduction. Policy forum: the future of the fetal tissue bank. Science. 262:1663-1665.
25. Asa SL, Kovacs K, Horvath E, et al. 1988 Human fetal adenohypophysis. Electron microscopic and ultrastructural immunocytochemical analysis. Neuroendocrinology. 48:423-431.
26. Asa SL, Kovacs K, Singer W. 1991 Human fetal adenohypophysis: morphologic and functional analysis in vitro. Neuroendocrinology. 53:562-572.
27. Goodyer CG., Branchaud CL, Lefebvre Y. 1993 Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human fetal pituitaries. J Clin Endocrinol Metab. 76:1259-1264.
28. Penalva A, Carballo A, Pombo M, Casanueva FF, Dieguez C. 1993 Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. J Clin Endocrinol Metab. 76:168-171.
29. 2 in rat primary pituitary cell monolayer culture. Endocrinology. 116:952-957.
30. 2 stimulate growth hormone release through distinct receptor sites. J Endocrinol. 129:11-19.
31. 2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′5′-monophosphate accumulation in rat pituitary cell culture. Endrocrinology. 124:2791-2798.
32. Guillaume V, Magnan E, Cataldi M, et al. 1994 GH-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology. 135:1073-1076.
33. Clark RG, Carlsson L, Trojnar J, Robinson IC. 1989 The effect of growth hormone-releasing peptide and growth hormone-releasing factor on conscious and anaesthetized rats. J Neuroendocrinol. 1:249-255.
34. Thomas GB, Fairhall KM, Robinson IC. 1997 Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6 in rats. Endocrinology. 138:1585-1591.
35. Frieboes RM, Murck H, Maier P, Schier T, Holsboer F, Steiger A. 1995 Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology. 61:584-589.